Sculptor Capital LP - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 69 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 4.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sculptor Capital LP ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$2,352,000
-0.3%
375,000
-2.5%
0.01%0.0%
Q2 2017$2,358,000384,6000.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders